Wearable Health Solutions (WHSI) 10-K 13 Oct 22 2022 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Jun. 30, 2022	Sep. 30, 2022
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2022
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--06-30
Entity File Number	333-153290
Entity Registrant Name	Wearable Health Solutions, Inc.
Entity Central Index Key	0001443089
Entity Tax Identification Number	26-3534190
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	2901 Pacific Coast Highway
Entity Address, Address Line Two	Suite 200
Entity Address, City or Town	Newport Beach
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92663
City Area Code	949
Local Phone Number	270.7460
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	No
Entity Interactive Data Current	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float	$ 8,701,413
Entity Common Stock, Shares Outstanding		1,531,592,608
Auditor Firm ID	5036
Auditor Name	Assurance Dimensions
Auditor Location	Margate, Florida

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jun. 30, 2022	Jun. 30, 2021
Current Assets
Cash and cash equivalents	$ 70,505	$ 847,430
Accounts receivable, net	0	25,694
Due from related parties (See Footnote 9)	155,800	0
Accounts receivable, other	2,000	2,000
Inventory	7,064	0
Prepaid Inventory	62,040	22,682
Prepaid expenses	0	10,000
Total Current Assets	297,409	907,806
Property, Plant and Equipment
Dealer Portal (net of $8,349 and $0 depreciation, as of June 30, 2022 and June 30, 2021)	41,651	0
Total Property, Plant and Equipment	41,651	0
Total Assets	339,060	907,806
LIABILITIES and SHAREHOLDERS' DEFICIT
COMMITMENTS AND CONTINGENCIES (Note 10)
Current liabilities
Accounts payable	57,940	331,876
Accrued expenses and other current liabilities	374,278	296,920
Accrued expenses - related party	213,840	579,673
Deferred revenue	80,880	108,298
Line of credit	397,500	397,500
Derivative liability	0	281,845
Notes payable	413,099	853,244
Note payable - other	50,000	50,000
Note payable - related party	170,000	425,000
Convertible notes - Leonite	0	260,000
Convertible notes - other	673,750	673,750
Total current liabilities	2,431,287	4,258,106
TOTAL LIABILITIES	2,431,287	4,258,106
Common stock
Common Stock: $0.0001 par value; 3,000,000,000 shares authorized, 1,493,142,608 and 647,074,177 shares issued and outstanding as of June 30, 2022 and 2021, respectively	149,314	64,708
Common stock to be issued (35,602,500 and 20,050,000 shares as of June 30, 2022 and 2021, respectively)	407,677	169,005
Additional paid in capital	36,773,035	22,732,295
Accumulated deficit	(39,423,382)	(26,374,227)
Total Shareholders’ Deficit	(2,092,227)	(3,350,300)
Total Liabilities and Shareholders’ Deficit	339,060	907,806
Series A Preferred Stock [Member]
SHAREHOLDERS’ DEFICIT
Preferred stock	1	1
Series B Preferred Stock [Member]
SHAREHOLDERS’ DEFICIT
Preferred stock	1	1
Series C Preferred Stock [Member]
SHAREHOLDERS’ DEFICIT
Preferred stock	684	684
Series D Preferred Stock [Member]
SHAREHOLDERS’ DEFICIT
Preferred stock	43	43
Series E Preferred Stock [Member]
SHAREHOLDERS’ DEFICIT
Preferred stock	400	190
Preferred stock to be issued	$ 0	$ 57,000

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Jun. 30, 2022	Jun. 30, 2021
Depreciation	$ 8,349	$ 0
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	25,000,000	25,000,000
Preferred Stock to be issued	0	100,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	3,000,000,000	3,000,000,000
Common stock, shares issued	1,493,142,608	647,074,177
Common stock, shares outstanding	1,493,142,608	647,074,177
Common stock to be issued	35,602,500	20,050,000
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	100,000	100,000
Preferred stock, shares issued	688	688
Preferred stock, shares outstanding	688	688
Series B Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	62,500	62,500
Preferred stock, shares issued	9,938	9,938
Preferred stock, shares outstanding	9,938	9,938
Series C Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	6,944,445	6,944,445
Preferred stock, shares issued	6,838,889	6,838,889
Preferred stock, shares outstanding	6,838,889	6,838,889
Series D Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	425,000	425,000
Preferred stock, shares outstanding	425,000	425,000
Series E Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	4,000,000	4,000,000
Preferred stock, shares issued	4,000,000	1,900,000
Preferred stock, shares outstanding	4,000,000	1,900,000

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Revenue	$ 1,045,890	$ 1,394,149
Cost of sales	(568,409)	(869,450)
Gross profit	477,481	524,699
Operating expenses
Selling expense	372,553	104,288
Consulting and professional fees	861,301	245,786
Gain/loss on debt settlement	0	(14,843)
Insurance	87,576	50,683
Rent	16,605	15,325
Salaries and wages (including stock compensation expense)	11,375,405	2,425,018
Software expense	0	144,600
Depreciation	8,349	0
Research and development expense	390,828	0
General and administrative	409,444	715,522
Total Operating expenses	13,522,061	3,686,379
Loss from operations	(13,044,580)	(3,161,680)
Other Income / (expense), net
Other income	36,000	0
Gain on debt extinguishment	96,145	0
Change in fair value of derivative instrument	(213,053)	(11,003)
Gain on debt forgiveness	0	81,000
Gain on settlement of accounts payable	156,616	0
Interest expense	(80,283)	(221,323)
Total other (expense), net	(4,575)	(151,326)
Net loss before taxes	(13,049,155)	(3,313,006)
Income tax	0	0
Net loss	$ (13,049,155)	$ (3,313,006)

Consolidated Statements of Op_2

Consolidated Statements of Operations (Parenthetical) - $ / shares	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Earnings Per Share, Basic	$ (0.01202)	$ (0.00629)
Earnings Per Share, Diluted	$ (0.01202)	$ (0.00629)
Weighted Average Number of Shares Outstanding, Basic	1,086,059,256	526,577,492
Weighted Average Number of Shares Outstanding, Diluted	1,086,059,256	526,577,492

Consolidated Statement of Share

Consolidated Statement of Shareholders' Deficit - USD ($)	Preferred Stock Series A [Member]	Preferred Stock Series B [Member]	Preferred Stock Series C [Member]	Series C To Be Issued [Member]	Preferred Stock Series D [Member]	Preferred Stock Series E [Member]	Series E To Be Issued [Member]	Common Stock [Member]	Common Stock To Be Issued [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
As at June 30, 2021 at Jun. 30, 2020	$ 1	$ 1	$ 14	$ 375,200	$ 43	$ 400	$ 650,000	$ 29,740	$ 71,415	$ 18,578,122	$ (23,061,221)	$ (3,356,285)
Beginning balance, shares at Jun. 30, 2020	688	9,938	138,886	6,700,003	425,000	4,000,000	1,000,000	297,399,177	10,350,000
Loss for the period											(3,313,006)	(3,313,006)
3a10 stock issuance								$ 4,899				4,899
[custom:Stock3a10SharesShares]								48,989,000
Cancellation of 3a10 agreement								$ (4,899)				(4,899)
[custom:CancellationOf3a10AgreementShares]								(48,989,000)
Issuance of Series C Preferred shares			$ 670	$ (375,200)						374,530
Issuance of Series C Preferred shares, shares			6,700,003	(6,700,000)
Return of preferred stock						$ (400)						(400)
Return of preferred stock, shares						(4,000,000)
Preferred stock issued/officer compensation						$ 190	$ (593,000)			1,162,810		570,000
Preferred stock issued/officer compensation , shares						1,900,000	(900,000)
Common stock issued/officer comp								$ 20,128	$ (2,410)	1,129,373		1,147,090
[custom:CommonStockIssuedOfficerCompensationShares]								201,275,000	(300,000)
Stock for services								$ 300		48,000		48,300
Stock Issued During Period, Shares, Issued for Services								3,000,000
Shares sold for cash								145,400,000	10,000,000
Shares sold for cash								$ 14,540	$ 100,000	1,439,460		1,554,000
As at June 30, 2022 at Jun. 30, 2021	$ 1	$ 1	$ 684		$ 43	$ 190	$ 57,000	$ 64,708	$ 169,005	22,732,295	(26,374,227)	(3,350,300)
Ending balance, shares at Jun. 30, 2021	688	9,938	6,838,889		425,000	1,900,000	100,000	647,074,177	20,050,000
Loss for the period											(13,049,155)	(13,049,155)
Common stock issued for debt conversions								$ 6,641		671,066		677,707
[custom:CommonStockIssuedForDebtConversionShares]								66,418,431
Issuance of shares for cash								$ 35,000	$ (100,005)	3,465,004		3,399,999
Stock Issued During Period, Shares, Other								350,000,000	(10,050,000)
Common stock for compensation								$ 40,965	$ 88,551	6,515,880		6,645,396
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture								409,650,000	7,262,500
Common stock for officer compensation									$ 104,126			104,126
Preferred stock issued/officer compensation						$ 210	$ (57,000)			3,056,790		3,000,000
Preferred stock issued/officer compensation , shares						2,100,000	(100,000)
[custom:CommonStockIssuedOfficerCompensationShares]									6,840,000
Stock for services								$ 2,000	$ (69,000)	362,000		295,000
Stock Issued During Period, Shares, Issued for Services								20,000,000	(10,000,000)
Shares sold for cash									21,500,000
Shares sold for cash									$ 215,000			215,000
Subscriptions receivable										(30,000)		(30,000)
As at June 30, 2022 at Jun. 30, 2022	$ 1	$ 1	$ 684		$ 43	$ 400		$ 149,314	$ 407,677	$ 36,773,035	$ (39,423,382)	$ (2,092,227)
Ending balance, shares at Jun. 30, 2022	688	9,938	6,838,889		425,000	4,000,000		1,493,142,608	35,602,500

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flow from operating activities
Net loss	$ (13,049,155)	$ (3,313,006)
Adjustment for non-cash charges and other items:
Depreciation	8,349	0
Default penalty on debt	0	110,000
Common stock issued for services	0	48,300
Stock compensation expense	10,044,522	1,816,702
Change in fair value of derivative instrument	213,053	11,003
Amortization of debt discount and original issue discount	0	4,167
Gain on settlement of accounts payable	(156,616)	0
Gain on debt extinguishment	(96,145)	(81,000)
Total adjustments	(3,035,992)	(1,403,834)
Changes in working capital
Decrease / (increase) in accounts receivables	25,694	12,596
Decrease / (increase) in inventory	(7,064)	0
Decrease / (increase) in prepaid inventory	(39,358)	85,129
Decrease / (increase) in prepaid expenses	10,000	(10,000)
Decrease / (increase) in other assets	0	(2,000)
(Decrease) / increase in trade and other payables	(117,320)	105,356
(Decrease) / increase in accrued expenses	84,281	103,192
(Decrease) / increase in deferred revenue	(27,418)	(63,809)
Total changes in working capital	(71,185)	230,464
Cash flow used in operating activities	(3,107,177)	(1,173,370)
Cash flow used in investing activities
Purchase of property, plant & equipment	(50,000)	0
Cash flow used in investing activities	(50,000)	0
Cash flow provided by financing activities
Proceeds from issuance of stock (net of subscriptions receivable)	3,584,399	1,454,000
Payments to related parties	(509,002)	0
Proceeds from notes payable	25,000	615,000
Repayments of note payable	(720,145)	(48,200)
Cash flow from financing activities	2,380,252	2,020,800
Increase/(decrease) in cash and cash equivalents	(776,925)	847,430
Cash and cash equivalents at beginning of the year	847,430	0
Cash and cash equivalents at end of the year	70,505	847,430
Cash paid during the periods for:
Interest	0	0
Taxes	$ 0	$ 0

Nature and Continuance of Opera

Nature and Continuance of Operations	12 Months Ended
	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature and Continuance of Operations	Note 1 – Nature and Continuance of Operations Wearable Healthcare Solutions Inc. (the “Company”) was incorporated as Medical Alarm Concepts Holding, Inc. on June 4, 2008 under the laws of the State of Nevada. The Company was formed for the sole purpose of acquiring all of the membership units of Medical Alarm Concepts LLC, a Pennsylvania limited liability company (“Medical LLC”). On May 26, 2016, the Company filed its Amended and Restated Articles of Incorporation with the Secretary of State of the State of Nevada to change its name from “Medical Alarm Concepts, Inc.” to “Wearable Health Solutions Inc.” The Company provides mobile health (mHealth) products and services to be used by customers in case of an emergency. As a provider of personal emergency devices, the Company provides innovative wearable healthcare products, tracking services, and turn-key solutions that enable our users to be proactive with their health, as well as safe and protected. The Company’s flagship products are the iHelp devices, the 3G and the next generation iHelp MAX™

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 – Summary of Significant Accounting Policies Basis of Presentation and Use of Estimates The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of financial statements. Principles of Consolidation Cash and Cash Equivalents Accounts Receivable 0 25,694 0 23,705 Software Development for Internal Use Concentration of Credit Risk Recognition of Revenues The Company’s revenues are derived principally from utilizing new technology in the medical alarm industry to provide 24-hour personal response monitoring services and related products to subscribers with medical- or age-related conditions. The Company recognizes revenue when it is realized or realizable and earned. For hardware sales, the Company recognizes revenues at a point in time when the product is shipped. Customers are billed on Net 30 terms. For service revenue, the Company recognizes revenues over the term of the service contract and when the services are rendered. For customers who pay several months at a time, the Company records revenues for the month’s services and the balance of funds to deferred revenues, and records the balance of revenues as they become current. Schedule of revenues REVENUES 2022 2021 Hardware revenue $ 134,045 $ 399,602 Service revenue 911,845 994,547 TOTAL REVENUES $ 1,045,890 $ 1,394,149 Deferred revenue activity for the years ended June 30, 2022 and 2021 was as follows: Schedule of deferred revenue DEFERRED REVENUE 2022 2021 Balance at beginning of period $ 108,298 $ 127,107 Deferred revenue recognized upon shipments to customers 229,127 285,285 Revenues recognized to end customers (256,545 ) (304,094 ) Balance at end of period $ 80,880 $ 108,298 Deferred Taxes ASC 740, Income Taxes, requires a company to first determine whether it is more likely than not (which is defined as a likelihood of more than fifty percent) that a tax position will be sustained based on its technical merits as of the reporting date, assuming that taxing authorities will examine the position and have full knowledge of all relevant information. A tax position that meets this more-likely-than-not threshold is then measured and recognized at the largest amount of benefit that is greater than fifty percent likely to be realized upon effective settlement with a taxing authority. The Federal and state income tax returns of the Company for 2022, 2021, and 2020 are subject to examination by the Internal Revenue Service and state taxing authorities for three (3) years from the date filed. Related Party Transactions a. Affiliates of the Company; b. Entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c. Trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d. Principal owners of the Company; e. Management of the Company; f. Other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. Other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. The financial statements include disclosures of material related party transactions, other than compensation arrangements, expense allowances and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of financial statements is not required in those statements. The disclosures shall include: a. The nature of the relationship involved; b. A description of the transactions, including transactions to which no amounts or nominal amounts were ascribed for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. The dollar amount of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. Amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement. Fair Value of Financial Instruments Level 1 Level 2 Level 3 From time to time, our financial instruments include cash, accounts payable and accrued expenses, convertible notes, lines of credit, and credit cards. Research and Development 390,828 0 Basic and Diluted Loss per Common Share - Schedule of anti-dilutive shares Basis of conversion Dilution 2022 2021 Series A Convertible 688 shares outstanding 1 share A: 2 shares 1,376 1,376 Series B Convertible 9,938 shares outstanding 1 share B: 2 shares 19,876 19,876 Series C Convertible 6,838,889 shares outstanding 1 share C: 10 shares 68,388,890 68,388,890 Series D Convertible 425,000 shares outstanding 1 share D: 10 shares 4,250,000 4,250,000 Series E Convertible 4,000,000 and 1,900,000 shares outstanding in 2022 and 2021, respectively 1 share E: 100 shares 400,000,000 190,000,000 Shares to be issued -0- and 100,000 Series E shares to be issued in 2022 and 2021, respectively 1 share E: 100 shares – 10,000,000 -0- and 20,050,000 shares of common stock to be issued in 2022 and 2021, respectively – 20,050,000 472,660,142 292,710,142 Because the Company incurred losses for the past two years, the basic and diluted share bases will be presented as the same. For the years ended June 30, 2022 and 2021, the Company incurred losses of ($0.01202) and ($0.00629) per basic share and diluted share, respectively. Recent Accounting Pronouncements In February 2016, the Financial Accounting Standards Board (FASB) published the new standard for leasing accounting according to US GAAP (ASU 2016-02 “Leases”; ASC Topic 842). Depending on the company, the new standard is to be applied for the first time for the financial years beginning after December 15, 2018 or after December 15, 2019. According to ASC Topic 842, the lessee has to record a right of use and a leasing liability in his financial statements at the beginning of the transfer of use. The Company adopted the new lease standard during the first quarter of fiscal year 2020. The Company has no leases which meet the criteria. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) – Simplifying the Accounting for Income Taxes. The update is intended to simplify the current rules regarding the accounting for income taxes and addresses several technical topics including accounting for franchise taxes, allocating income taxes between a loss in continuing operations and in other categories such as discontinued operations, reporting income taxes for legal entities that are not subject to income taxes, and interim accounting for enacted changes in tax laws. The new standard is effective for fiscal years beginning after December 15, 2020; however, early adoption is permitted. The Company does not expect the adoption of this standard have a material impact on the consolidated financial statements. In August 2020, the FASB issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity’s own equity. Among other changes, ASU 2020-06 removes from U.S. GAAP the liability and equity separation model for convertible instruments with a cash conversion feature, and as a result, after adoption, entities will no longer separately present in equity an embedded conversion feature for such debt. Similarly, the embedded conversion feature will no longer be amortized into income as interest expense over the life of the instrument. Instead, entities will account for a convertible debt instrument wholly as debt unless (1) a convertible instrument contains features that require bifurcation as a derivative under ASC Topic 815, Derivatives and Hedging, or (2) a convertible debt instrument was issued at a substantial premium. Among other potential impacts, this change is expected to reduce reported interest expense, increase reported net income, and result in a reclassification of certain conversion feature balance sheet amounts from shareholders’ equity to liabilities as it relates to the Company’s convertible senior notes. Additionally, ASU 2020-06 requires the application of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share (EPS), which is consistent with the Company’s accounting treatment under the current standard. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, with early adoption permitted for fiscal years beginning after December 15, 2020, and can be adopted on either a fully retrospective or modified retrospective basis. The Company is currently evaluating the timing, method of adoption and overall impact of this standard on its consolidated financial statements. The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the consolidated financial position, statements of operations and cash flows.

Going Concern

Going Concern	12 Months Ended
	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 3 – Going Concern The accompanying consolidated financial statements for the years ended June 30, 2022 and 2021 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As of June 30, 2022, the Company has incurred losses for the last two years, and has an accumulated deficit of $( 39,423,382 26,374,227 During the year ended June 30, 2022, Company has net cash used in operating activities of $ 3,107,177 10,044,522 13,049,155 2,380,252 2,133,878 Management believes that the Company’s capital requirements will depend on many factors, including the success of the Company’s development efforts and its efforts to raise capital. Management also believes the Company needs to raise additional capital for working capital purposes. There can be no assurance that the Company will be able to obtain the additional capital resources necessary to implement its business plan or that any assumptions relating to its business plan will prove accurate. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.

Inventory, Prepaid Inventory an

Inventory, Prepaid Inventory and Prepaid Expenses	12 Months Ended
	Jun. 30, 2022
Inventory Disclosure [Abstract]
Inventory, Prepaid Inventory and Prepaid Expenses	Note 4 – Inventory, Prepaid Inventory and Prepaid Expenses The Company maintains some inventories in house and purchases some of its inventory overseas. Inventories, except for stock in transit are stated at the lower of cost and net realizable value. Stock in transit is valued at cost comprising invoice value plus other charges thereon. Net realizable is the estimated selling price in ordinary course of business less estimated costs of completion and selling expenses. The quantity of inventory may vary from time to time depending on the delivery schedule of overseas shipments. Inventory and prepaid inventory are valued at lower of cost or net realizable value, comprising invoice value plus other charges thereon. Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and selling expenses. Prepaid expenses are valued at cost. Schedule of inventory 2022 2021 Inventory $ 7,064 $ – 2022 2021 Prepaid inventory $ 62,040 $ 22,682 2022 2021 Prepaid expenses $ – $ 10,000

Property, Plant, and Equipment

Property, Plant, and Equipment and Boapin	12 Months Ended
	Jun. 30, 2022
Property, Plant and Equipment [Abstract]
Property, Plant, and Equipment and Boapin	Note 5 – Property, Plant, and Equipment and Boapin The Company has $20,000 in furnishings, $19,689 in office computers and equipment, and capitalized software development costs of $45,900 which are fully depreciated. On August 30, 2021, the Company purchased its dealer portal for $50,000 for internal use, amortized over 60 months. As of June 30, 2022 and June 30, 2021, the Company recorded $ 41,651 0 Schedule of property, plant and equipment 2022 2021 Furniture $ 20,000 $ 20,000 Office computers, equipment, software 19,689 19,689 Software development costs 45,900 45,900 Dealer portal 50,000 – Property, plant, and equipment 135,589 85,589 Less accumulated depreciation (93,938 ) (85,589 ) Net property, plant, and equipment $ 41,651 $ –

Accounts payable and accrued ex

Accounts payable and accrued expenses and liabilities	12 Months Ended
	Jun. 30, 2022
Payables and Accruals [Abstract]
Accounts payable and accrued expenses and liabilities	Note 6 – Accounts payable and accrued expenses and liabilities The Company recorded Accounts Payable of $ 57,940 331,876 Accrued expenses and other current liabilities are expenses that have been incurred but not yet paid and primarily include legal fees, audit fees, and other professional fees, as well as interest accrued in connection with credit lines and notes payable. The Company recorded $ 374,278 296,920 3a10 agreement On August 17, 2020, the Company entered into a settlement agreement and stipulation (“Settlement Agreement”) with Trillium Partners LP (“Trillium”) in connection with the settlement of $ 310,494 In October 2020, the Company issued 48,989,000 shares of WHSI common stock, to be valued at 60% of the lowest bid price for the common stock on the date of the stock issuance. Subsequently, in April 2021, the agreement was voided for non-participation, and all 48,989,000 shares were returned to treasury.

Notes Payable and Notes Payable

Notes Payable and Notes Payable - Other	12 Months Ended
	Jun. 30, 2022
Debt Disclosure [Abstract]
Notes Payable and Notes Payable - Other	Note 7 – Notes Payable and Notes Payable - Other Notes payable consists of line of credit, notes payable incurred by our subsidiary, notes payable-other, convertible notes payable, notes payable for stock purchases under Reg A, and short-term bridge loans, as follows: Short term bridge loan - COHEN On July 31, 2020, the Company secured a $ 500,000 12 12 At June 30, 2021, the Company had recorded short term note payable of $ 500,000 55,027 On August 19, 2021, the Company repaid $ 300,000 100,000 At June 30, 2022, the Company recorded a short term note payable of $ 100,000 21,649 76,677 Note payable – stock purchases under Reg A In March 2021 and June 2021, the Company accepted payments of $ 115,000 At June 30, 2022 and 2021, the Company has recorded $ 115,000 115,000 1,539 1,539 Note Payable – Other In November 2016, the Company secured a $ 50,000 4 As of June 30, 2022 and 2021, the Company expensed $ 2,000 2,000 11,283 9,283 Convertible note payable – BENZA, D2CF On March 1, 2016 and March 3, 2016, the Company closed a private placement of debt and received an aggregate of $612,500 by issuing $ 13,750 660,000 The Company is currently in negotiations to settle the $660,000 BENZA loan with principles in the company, although there has been no settlement to date. As of June 30, 2022 and 2021, the Company reported $ 673,750 673,750 Convertible note payable: Leonite Capital, LLC On November 19, 2019, the Company, together with Hypersoft Ventures (collectively, the “Borrower”), received $ 135,000 150,000 15,000 2,700,000 260,000 The Company has determined that the conversion feature embedded in the Leonite Convertible Note constitutes a derivative and has been bifurcated from the Leonite Convertible Note and recorded as a derivative liability, with a corresponding discount recorded to the associated debt, on the accompanying balance sheet, and revalued to fair market value at each reporting period. The initial issuance yielded a derivative liability of $ 94,225 Significant assumptions used in calculating fair value of conversion feature of Leonite Convertible Note at issuance date are as follows: Notes Payable - Schedule of assumptions Expected Dividends Expected volatility Risk-free rate of interest Expected term (year) Exercise (Conversion) price Common stock price per share 0.00% 809.71% 0.0154% 0.75 $0.02 $ 0.01300 On June 4, 2021, the Company and Leonite renegotiated the convertible note for two years, face value of $260,000. At June 30, 2021, the Company recorded $ 281,845 On July 29, 2021, Leonite converted $ 42,750 2,250 15,000,000 44,475 2,250 10,269,253 On October 6, 2021, Leonite converted $ 57,952 2,250 13,231,209 125,000 2,250 27,917,969 96,145 Schedule of extinguishment of debt Balance at June 30, 2021 $ 260,000 Accrued interest 9,954 Leonite Convertible Note converted (269,954 ) Total – Less: debt discount – Balance at June 30, 2022 $ – The resulting derivative valuation is calculated as follows: Schedule of derivative liabilities at fair value Derivative as of June 30, 2021 $ 281,845 Change in fair value 213,053 494,898 Write off due to conversions (398,753 ) 96,145 Gain on extinguishment (96,145 ) Derivative as of June 30, 2022 $ – Significant assumptions used in calculating fair value of conversion feature of Leonite convertible Note as of June 30, 2022 are as follows. Note Payable - Schedule of assumptions Expected Dividends Expected volatility Risk-free rate of interest Expected term (year) Exercise (Conversion) price Common stock price per share 0.00% 269.75% 0.0007% 1.9288 $0.00550 $ 0.010 As of June 30, 2022 and June 30, 2021, the Company has recorded $- 0 260,000 Credit line – MediPendant New York Inc. On September 30, 2014, the subsidiary received a line of credit with Medi Pendant New York, Inc. (“MNY). Under the original terms of the line of credit agreement, the Company was able to borrow up to $ 500,000 6.5 September 30, 2017 500,000 200,000 25,653 8,436 397,500 397,500 Notes Payable - subsidiary The Company has various loans and credit lines outstanding. The credit line carries an interest rate of 16.24 9.24 10.90 Schedule of notes payable 2022 2021 Wells Fargo Loan $ 8,770 $ 12,454 On Deck Loan 139,569 139,569 Susquehanna Salt Loan 10,500 52,500 Prosper Loans 9,994 17,771 MARCUS Loan 5,410 15,950 Notes payable - subsidiary 174,243 238,244 Loans – See Stock purchases under Reg A and short-term bridge loans 238,856 615,000 TOTAL LOANS $ 413,099 $ 853,244 As of June 30, 2022 and 2021, the Company has outstanding $ 413,099 853,244 Notes Payable - SBA The Company obtained SBA loans through pandemic offerings in 2020. As of March 2, 2021, the loans were forgiven, and the Company recorded gain on debt forgiveness of $ 81,000 Debt settlement – On Deck, Susquehanna, MCA Cure In 2019, our subsidiary engaged MCA CURE to negotiate settlements with two creditors: On Deck and Susquehanna Salt, noted in the table above. The Company ceased paying the loan payments and paid to MCA Cure $ 43,875 47,000 90,875 0 0 139,569 139,569 10,500 52,500

Shareholders_ (Deficit)

Shareholders’ (Deficit)	12 Months Ended
	Jun. 30, 2022
Equity [Abstract]
Shareholders’ (Deficit)	Note 8 – Shareholders’ (Deficit) Preferred Stock: Series A Convertible Preferred Stock 100,000 0.0001 688 Series B Convertible Preferred Stock 62,500 0.0001 9,938 Series C Convertible Preferred Stock 6,944,445 0.0001 The Company issued 6,700,003 6,838,889 Series D Convertible Preferred Stock : 500,000 0.0001 425,000 Series E Convertible Preferred Stock : 4,000,000 0.0001 Each of these shares carries a voting right equivalent to 10,000 shares of common stock. In November 2019, 4,000,000 200,000,000 1,000,000 650,000 .65 During the year ended June 30, 2021, as part of the change in control, 4,000,000 1,000,000 450,000 900,000 513,000 0.57 100,000 57,000 1,000,000 3,000,000 As of June 30, 2022 and 2021, 4,000,000 1,900,000 Common Stock The Company is currently authorized to issue 3,000,000,000 0.0001 25,000,000 0.0001 During the period ended June 30, 2021, the Company · issued 200,000,000 1,140,000 · accrued 150,000 1,500 · issued 1,275,000 8,518 · issued 3,000,000 48,300 · sold 145,400,000 · accrued 10,000,000 100,000 All shares were recorded at the stock price of the date of agreement or grant. During the period ended June 30, 2022, the Company · issued a total of 409,650,000 shares of common stock for a total value of $ 6,556,845 · issued 66,418,431 260,000 9,954 9,000 677,707 · issued 10,000,000 48,300 · sold 360,000,000 · accrued 7,262,500 shares of common stock for officer’s compensation and bonuses, valued at $ 104,126 or $0.0143 shares, and · accrued 6,840,000 88,551 All shares were recorded at the quoted stock price of the date of agreement or grant. As of June 30, 2022 and 2021, the Company had 1,493,142,608 647,074,177

Related Party Transactions

Related Party Transactions	12 Months Ended
	Jun. 30, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Note 9 – Related Party Transactions Note payable – BOAPIN purchase In August 2020, and effective as of June 30, 2020, the Company purchased the BOAPIN portal, including all software, licensing, and ownership rights from Hypersoft Ventures, Inc., a related party through common ownership, for $800,200, which includes six million seven hundred thousand three (6,700,003) shares of Series C Convertible Preferred stock, valued at $375,200 or $0.056 per share, based on the conversion of one share of Series C Preferred stock for 10 shares of common stock and the stock price on the date of the transaction, and a note payable for $425,000, bearing eight percent (8%) interest with no prepayment or delinquency clauses. As of June 30, 2022 and 2021, the Company recorded Note payable-BOAPIN of $ 170,000 425,000 49,415 28,225 21,190 28,225 Related party debt, net From time to time, the Company received funds from related parties for day-to-day operations. These are short-term loans which bear no interest, and the Company expects to repay these loans by the end of the fiscal year following the year in which the short-term loan was made. At June 30, 2022, the Company had a receivable from certain management employees totaling $155,800. The total receivable balance was subsequently collected by the Company on September 27, 2022. Schedule of related party transactions 2022 2021 Related parties – subsidiary $ 202,875 $ 263,473 Due from related parties (155,800 ) – Accrued salaries, bonus, fees 10,965 316,200 Total loans from related parties, net $ 58,040 $ 579,673

Commitments and contingencies

Commitments and contingencies	12 Months Ended
	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	Note 10 – Commitments and contingencies Legal Matters From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. 1) Wearable Health Solutions, Inc. v. Barry Honig, GRQ Consultants Inc., Benza Pharma LLC and John Does 1-10, Supreme Court of the State of New York County of New York, July 22, 2021. Company is disputing the validity of Notes from 3/2016 and seeking damages, reparations, and related costs. 2) GRQ Consultants, Inc. v. Wearable Health Solutions, Inc., Supreme Court of the State of New York, County of New York, August 26, 2021, Parties are seeking summary judgment of $50,000 plus accrued interest in response to lawsuit by Company regarding $50,000 loan from 11/2016. 3) Benza Pharma LLC, Sandor Capital, LP, and John Lema v. Wearable Health Solutions, Inc., District Court, Clark County, Nevada, Parties are seeking summary judgment of $3,000,000plus accrued interest in regards to convertible notes payable from March, 2016. 4) Medical Alarm Concepts LLC v. MCA Cure, LLC, Superior Court of New Jersey, Law Division, Morris County. Company is seeking return of payments for non-performance plus attorney fees and court costs. A settlement was reached between the parties whereby MCA Cure will pay an initial $10,000 and $6,500 each month until debt is satisfied in 2023 (See Note 11). Commitments and Contingencies. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows. Office lease The Company maintains its corporate office at 2901 W. Coast Highway, Suite 200, Newport Beach, CA 92663. The Company currently pays $175 a month for its office space and the term is month-to-month. The Company’s subsidiary maintains a warehouse office in Pennsylvania to facilitate inventory arrival and product shipment. The 3 year lease at $1,100 per month expired on September 30, 2021, and was renewed for 12 months at $1,300 per month beginning October 1, 2021 and expiring on September 30, 2022. The subsidiary is currently in a month-to-month arrangement with this office warehouse. Expenditures for the years ending June 30, 2022 and 2021 are as follows: Schedule lease cost 2022 2021 Rent expense $ 15,700 $ 15,325

Other income - settlement

Other income - settlement	12 Months Ended
	Jun. 30, 2022
Other Income and Expenses [Abstract]
Other income - settlement	Note 11 – Other income - settlement Settlement In 2019, the Company engaged MCA Cure to negotiate settlements with two note holders, and paid MCA Cure a total of $ 97,625 105,125 As of June 30, 2022 and 2021, the Company has recorded $ 36,000 0

Income Taxes

Income Taxes	12 Months Ended
	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Note 12 – Income Taxes Deferred income tax assets and liabilities are computed annually for differences between financial statement and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense is the tax payable or refundable for the period plus or minus the change during the period in deferred tax assets and liabilities. The effective tax rate on the net loss before income taxes differs from the U.S. statutory rate as follows: Schedule of effective tax rate June 30, 2022 June 30, 2021 U.S. statutory rate 21.00 21.00 PA state corporate tax 9.99 9.99 Less valuation allowance (30.99 ) (30.99 ) Effective tax rate 0 0 The significant components of deferred tax assets and liabilities are as follows, expiring in 2023 and 2024, on net operating losses of $ 39,423,382 26,903,013 Schedule of deferred tax asset 2022 2021 Net deferred tax assets $ 12,217,306 $ 8,337,244 Less valuation allowance (12,217,306 ) (8,337,244 ) Deferred tax asset - net valuation allowance $ – $ – Uncertain Tax Positions.

Subsequent Events

Subsequent Events	12 Months Ended
	Jun. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 13 – Subsequent Events Common Stock During the period July 1, 2022 through September 30, 2022, the Company issued a total of 38,450,000 shares of common stock. The Company issued 11,950,000 shares for compensation to employees and officers valued at $167,263; 5,000,000 shares for services valued at $89,000; and, 21,500,000 shares for cash valued at $215,000. At September 30, 2022, the Company had 1,531,592,608 shares of common stock issued and outstanding. Shares for services and compensation were valued using the stock price on the date of the transactions. During August and September 2022, the Company received proceeds of $604,500 in connection with the issuance of 67,950,000 shares of common stock. On September 27, 2022, the Company received payments totaling $155,800 from certain management employees and as a result, the Company no longer has a receivable balance from any of its management employees as of the filing date of this Annual Report on Form 10-K.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation and Use of Estimates	Basis of Presentation and Use of Estimates The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of financial statements.
Principles of Consolidation	Principles of Consolidation
Cash and Cash Equivalents	Cash and Cash Equivalents
Accounts Receivable	Accounts Receivable 0 25,694 0 23,705
Software Development for Internal Use	Software Development for Internal Use
Concentration of Credit Risk	Concentration of Credit Risk
Recognition of Revenues	Recognition of Revenues The Company’s revenues are derived principally from utilizing new technology in the medical alarm industry to provide 24-hour personal response monitoring services and related products to subscribers with medical- or age-related conditions. The Company recognizes revenue when it is realized or realizable and earned. For hardware sales, the Company recognizes revenues at a point in time when the product is shipped. Customers are billed on Net 30 terms. For service revenue, the Company recognizes revenues over the term of the service contract and when the services are rendered. For customers who pay several months at a time, the Company records revenues for the month’s services and the balance of funds to deferred revenues, and records the balance of revenues as they become current. Schedule of revenues REVENUES 2022 2021 Hardware revenue $ 134,045 $ 399,602 Service revenue 911,845 994,547 TOTAL REVENUES $ 1,045,890 $ 1,394,149 Deferred revenue activity for the years ended June 30, 2022 and 2021 was as follows: Schedule of deferred revenue DEFERRED REVENUE 2022 2021 Balance at beginning of period $ 108,298 $ 127,107 Deferred revenue recognized upon shipments to customers 229,127 285,285 Revenues recognized to end customers (256,545 ) (304,094 ) Balance at end of period $ 80,880 $ 108,298
Deferred Taxes	Deferred Taxes ASC 740, Income Taxes, requires a company to first determine whether it is more likely than not (which is defined as a likelihood of more than fifty percent) that a tax position will be sustained based on its technical merits as of the reporting date, assuming that taxing authorities will examine the position and have full knowledge of all relevant information. A tax position that meets this more-likely-than-not threshold is then measured and recognized at the largest amount of benefit that is greater than fifty percent likely to be realized upon effective settlement with a taxing authority. The Federal and state income tax returns of the Company for 2022, 2021, and 2020 are subject to examination by the Internal Revenue Service and state taxing authorities for three (3) years from the date filed.
Related Party Transactions	Related Party Transactions a. Affiliates of the Company; b. Entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c. Trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d. Principal owners of the Company; e. Management of the Company; f. Other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. Other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. The financial statements include disclosures of material related party transactions, other than compensation arrangements, expense allowances and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of financial statements is not required in those statements. The disclosures shall include: a. The nature of the relationship involved; b. A description of the transactions, including transactions to which no amounts or nominal amounts were ascribed for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. The dollar amount of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. Amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Level 1 Level 2 Level 3 From time to time, our financial instruments include cash, accounts payable and accrued expenses, convertible notes, lines of credit, and credit cards.
Research and Development	Research and Development 390,828 0
Basic and Diluted Loss per Common Share	Basic and Diluted Loss per Common Share - Schedule of anti-dilutive shares Basis of conversion Dilution 2022 2021 Series A Convertible 688 shares outstanding 1 share A: 2 shares 1,376 1,376 Series B Convertible 9,938 shares outstanding 1 share B: 2 shares 19,876 19,876 Series C Convertible 6,838,889 shares outstanding 1 share C: 10 shares 68,388,890 68,388,890 Series D Convertible 425,000 shares outstanding 1 share D: 10 shares 4,250,000 4,250,000 Series E Convertible 4,000,000 and 1,900,000 shares outstanding in 2022 and 2021, respectively 1 share E: 100 shares 400,000,000 190,000,000 Shares to be issued -0- and 100,000 Series E shares to be issued in 2022 and 2021, respectively 1 share E: 100 shares – 10,000,000 -0- and 20,050,000 shares of common stock to be issued in 2022 and 2021, respectively – 20,050,000 472,660,142 292,710,142 Because the Company incurred losses for the past two years, the basic and diluted share bases will be presented as the same. For the years ended June 30, 2022 and 2021, the Company incurred losses of ($0.01202) and ($0.00629) per basic share and diluted share, respectively.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In February 2016, the Financial Accounting Standards Board (FASB) published the new standard for leasing accounting according to US GAAP (ASU 2016-02 “Leases”; ASC Topic 842). Depending on the company, the new standard is to be applied for the first time for the financial years beginning after December 15, 2018 or after December 15, 2019. According to ASC Topic 842, the lessee has to record a right of use and a leasing liability in his financial statements at the beginning of the transfer of use. The Company adopted the new lease standard during the first quarter of fiscal year 2020. The Company has no leases which meet the criteria. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) – Simplifying the Accounting for Income Taxes. The update is intended to simplify the current rules regarding the accounting for income taxes and addresses several technical topics including accounting for franchise taxes, allocating income taxes between a loss in continuing operations and in other categories such as discontinued operations, reporting income taxes for legal entities that are not subject to income taxes, and interim accounting for enacted changes in tax laws. The new standard is effective for fiscal years beginning after December 15, 2020; however, early adoption is permitted. The Company does not expect the adoption of this standard have a material impact on the consolidated financial statements. In August 2020, the FASB issued ASU No. 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity’s own equity. Among other changes, ASU 2020-06 removes from U.S. GAAP the liability and equity separation model for convertible instruments with a cash conversion feature, and as a result, after adoption, entities will no longer separately present in equity an embedded conversion feature for such debt. Similarly, the embedded conversion feature will no longer be amortized into income as interest expense over the life of the instrument. Instead, entities will account for a convertible debt instrument wholly as debt unless (1) a convertible instrument contains features that require bifurcation as a derivative under ASC Topic 815, Derivatives and Hedging, or (2) a convertible debt instrument was issued at a substantial premium. Among other potential impacts, this change is expected to reduce reported interest expense, increase reported net income, and result in a reclassification of certain conversion feature balance sheet amounts from shareholders’ equity to liabilities as it relates to the Company’s convertible senior notes. Additionally, ASU 2020-06 requires the application of the if-converted method to calculate the impact of convertible instruments on diluted earnings per share (EPS), which is consistent with the Company’s accounting treatment under the current standard. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, with early adoption permitted for fiscal years beginning after December 15, 2020, and can be adopted on either a fully retrospective or modified retrospective basis. The Company is currently evaluating the timing, method of adoption and overall impact of this standard on its consolidated financial statements. The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the consolidated financial position, statements of operations and cash flows.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Jun. 30, 2022
Accounting Policies [Abstract]
Schedule of revenues	Schedule of revenues REVENUES 2022 2021 Hardware revenue $ 134,045 $ 399,602 Service revenue 911,845 994,547 TOTAL REVENUES $ 1,045,890 $ 1,394,149
Revenues (Details - Deferred revenue)	Schedule of deferred revenue DEFERRED REVENUE 2022 2021 Balance at beginning of period $ 108,298 $ 127,107 Deferred revenue recognized upon shipments to customers 229,127 285,285 Revenues recognized to end customers (256,545 ) (304,094 ) Balance at end of period $ 80,880 $ 108,298
Schedule of anti-dilutive shares	Schedule of anti-dilutive shares Basis of conversion Dilution 2022 2021 Series A Convertible 688 shares outstanding 1 share A: 2 shares 1,376 1,376 Series B Convertible 9,938 shares outstanding 1 share B: 2 shares 19,876 19,876 Series C Convertible 6,838,889 shares outstanding 1 share C: 10 shares 68,388,890 68,388,890 Series D Convertible 425,000 shares outstanding 1 share D: 10 shares 4,250,000 4,250,000 Series E Convertible 4,000,000 and 1,900,000 shares outstanding in 2022 and 2021, respectively 1 share E: 100 shares 400,000,000 190,000,000 Shares to be issued -0- and 100,000 Series E shares to be issued in 2022 and 2021, respectively 1 share E: 100 shares – 10,000,000 -0- and 20,050,000 shares of common stock to be issued in 2022 and 2021, respectively – 20,050,000 472,660,142 292,710,142

Inventory, Prepaid Inventory _2

Inventory, Prepaid Inventory and Prepaid Expenses (Tables)	12 Months Ended
	Jun. 30, 2022
Inventory Disclosure [Abstract]
Schedule of inventory	Schedule of inventory 2022 2021 Inventory $ 7,064 $ – 2022 2021 Prepaid inventory $ 62,040 $ 22,682 2022 2021 Prepaid expenses $ – $ 10,000

Property, Plant, and Equipmen_2

Property, Plant, and Equipment and Boapin (Tables)	12 Months Ended
	Jun. 30, 2022
Property, Plant and Equipment [Abstract]
Schedule of property, plant and equipment	Schedule of property, plant and equipment 2022 2021 Furniture $ 20,000 $ 20,000 Office computers, equipment, software 19,689 19,689 Software development costs 45,900 45,900 Dealer portal 50,000 – Property, plant, and equipment 135,589 85,589 Less accumulated depreciation (93,938 ) (85,589 ) Net property, plant, and equipment $ 41,651 $ –

Notes Payable and Notes Payab_2

Notes Payable and Notes Payable - Other (Tables)	12 Months Ended
	Jun. 30, 2022
Debt Instrument [Line Items]
Schedule of extinguishment of debt	Schedule of extinguishment of debt Balance at June 30, 2021 $ 260,000 Accrued interest 9,954 Leonite Convertible Note converted (269,954 ) Total – Less: debt discount – Balance at June 30, 2022 $ –
Schedule of derivative liabilities at fair value	Schedule of derivative liabilities at fair value Derivative as of June 30, 2021 $ 281,845 Change in fair value 213,053 494,898 Write off due to conversions (398,753 ) 96,145 Gain on extinguishment (96,145 ) Derivative as of June 30, 2022 $ –
Schedule of notes payable	Schedule of notes payable 2022 2021 Wells Fargo Loan $ 8,770 $ 12,454 On Deck Loan 139,569 139,569 Susquehanna Salt Loan 10,500 52,500 Prosper Loans 9,994 17,771 MARCUS Loan 5,410 15,950 Notes payable - subsidiary 174,243 238,244 Loans – See Stock purchases under Reg A and short-term bridge loans 238,856 615,000 TOTAL LOANS $ 413,099 $ 853,244
Leonite Convertible Note November 2019 [Member]
Debt Instrument [Line Items]
Note Payable - Schedule of assumptions	Notes Payable - Schedule of assumptions Expected Dividends Expected volatility Risk-free rate of interest Expected term (year) Exercise (Conversion) price Common stock price per share 0.00% 809.71% 0.0154% 0.75 $0.02 $ 0.01300
Leonite Convertible Note June 2022 [Member]
Debt Instrument [Line Items]
Note Payable - Schedule of assumptions	Note Payable - Schedule of assumptions Expected Dividends Expected volatility Risk-free rate of interest Expected term (year) Exercise (Conversion) price Common stock price per share 0.00% 269.75% 0.0007% 1.9288 $0.00550 $ 0.010

Related Party Transactions (Tab

Related Party Transactions (Tables)	12 Months Ended
	Jun. 30, 2022
Related Party Transactions [Abstract]
Schedule of related party transactions	Schedule of related party transactions 2022 2021 Related parties – subsidiary $ 202,875 $ 263,473 Due from related parties (155,800 ) – Accrued salaries, bonus, fees 10,965 316,200 Total loans from related parties, net $ 58,040 $ 579,673

Commitments and contingencies (

Commitments and contingencies (Tables)	12 Months Ended
	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule lease cost	Schedule lease cost 2022 2021 Rent expense $ 15,700 $ 15,325

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Schedule of effective tax rate	Schedule of effective tax rate June 30, 2022 June 30, 2021 U.S. statutory rate 21.00 21.00 PA state corporate tax 9.99 9.99 Less valuation allowance (30.99 ) (30.99 ) Effective tax rate 0 0
Schedule of deferred tax asset	Schedule of deferred tax asset 2022 2021 Net deferred tax assets $ 12,217,306 $ 8,337,244 Less valuation allowance (12,217,306 ) (8,337,244 ) Deferred tax asset - net valuation allowance $ – $ –

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details - Schedule of Revenues) - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Product Information [Line Items]
Revenues	$ 1,045,890	$ 1,394,149
Hardware Revenue [Member]
Product Information [Line Items]
Revenues	134,045	399,602
Service Revenue [Member]
Product Information [Line Items]
Revenues	$ 911,845	$ 994,547

Revenues (Details - Deferred re

Revenues (Details - Deferred revenue) - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Accounting Policies [Abstract]
Contract with Customer, Liability, Current	$ 108,298	$ 127,107
Deferred Revenue, Revenue Recognized	229,127	285,285
[custom:RevenuesRecognizedToEndCustomers]	(256,545)	(304,094)
Contract with Customer, Liability, Current	80,880	108,298
Research and Development Expense	$ 390,828	$ 0

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details - Antidilutive information) - shares	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
AntiDilutive Shares	472,660,142	292,710,142
Series A Preferred Stock [Member]
AntiDilutive Shares	1,376	1,376
Series B Preferred Stock [Member]
AntiDilutive Shares	19,876	19,876
Series C Preferred Stock [Member]
AntiDilutive Shares	68,388,890	68,388,890
Series D Preferred Stock [Member]
AntiDilutive Shares	4,250,000	4,250,000
Series E Preferred Stock [Member]
AntiDilutive Shares	400,000,000	190,000,000
Series E Preferred Stock To Be Issued [Member]
AntiDilutive Shares	0	10,000,000
Shares To Be Issued [Member]
AntiDilutive Shares	0	20,050,000
Series A Convertible Stock [Member]
Basis of conversion	688 shares outstanding
Dilution	1 share A: 2 shares
Series B Convertible Stock [Member]
Basis of conversion	9,938 shares outstanding
Dilution	1 share B: 2 shares
Series C Convertible Stock [Member]
Basis of conversion	6,838,889 shares outstanding
Dilution	1 share C: 10 shares
Series D Convertible Stock [Member]
Basis of conversion	425,000 shares outstanding
Dilution	1 share D: 10 shares
Series E Convertible Stock [Member]
Basis of conversion	4,000,000 and 1,900,000 shares outstanding in 2022 and 2021, respectively
Dilution	1 share E: 100 shares
Series E Convertible Shares To Be Issued [Member]
Basis of conversion	-0- and 100,000 Series E shares to be issued in 2022 and 2021, respectively
Dilution	1 share E: 100 shares

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	Jun. 30, 2022	Jun. 30, 2021
Accounting Policies [Abstract]
Accounts receivable, net	$ 0	$ 25,694
Allowance for doubtful accounts	$ 0	$ 23,705

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit	$ 39,423,382	$ 26,374,227
Net cash used in operating activities	3,107,177	1,173,370
Stock compensation non-cash expenses	10,044,522	1,816,702
Net loss	13,049,155	3,313,006
Cash flow from financing activities	2,380,252	$ 2,020,800
Negative working capital	$ 2,133,878

Inventory, Prepaid Inventory _3

Inventory, Prepaid Inventory and Prepaid Expenses (Details - Schedule of inventory) - USD ($)	Jun. 30, 2022	Jun. 30, 2021
Inventory Disclosure [Abstract]
Inventory, net	$ 7,064	$ 0
Prepaid inventories	62,040	22,682
Prepaid expenses	$ 0	$ 10,000

Property, Plant, and Equipmen_3

Property, Plant, and Equipment and Boapin (Details) - USD ($)	Jun. 30, 2022	Jun. 30, 2021
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 135,589	$ 85,589
Less accumulated depreciation	(93,938)	(85,589)
Net property, plant, and equipment	41,651	0
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	20,000	20,000
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	19,689	19,689
Software Development [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	45,900	45,900
Dealer Portal [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 50,000	$ 0

Property, Plant, and Equipmen_4

Property, Plant, and Equipment and Boapin (Details Narrative) - USD ($)	Jun. 30, 2022	Jun. 30, 2021
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Other, Net	$ 41,651	$ 0

Accounts payable and accrued _2

Accounts payable and accrued expenses and liabilities (Details Narrative) - USD ($)	Aug. 17, 2020	Jun. 30, 2022	Jun. 30, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Accounts payable		$ 57,940	$ 331,876
Accrued liabilities		$ 374,278	$ 296,920
Trillium Partners L P [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Company owed to certain of creditors	$ 310,494

Notes Payable - Schedule of ass

Notes Payable - Schedule of assumptions (Details) - $ / shares	Jun. 30, 2022	Nov. 19, 2019
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Share Price	$ 0.010	$ 0.01300
Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected Term	0.00%	0.00%
Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected Term	269.75%	809.71%
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected Term	0.0007%	0.0154%
Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected Term	1.9288	0.75
Measurement Input, Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Expected Term	$0.00550	$0.02

Notes Payable and Note Payable

Notes Payable and Note Payable - Other (Details - Schedule of Extinguishment of Debt) - Leonite Capital [Member]	12 Months Ended
	Jun. 30, 2022 USD ($)
Debt Instrument [Line Items]
Convertible debt, beginning balance	$ 260,000
Convertible debt issued	9,954
Convertible debt converted	(269,954)
Convertible debt, beginning balance	0
Debt discount	0
Convertible debt, ending balance	$ 0

Notes Payable and Note Payabl_2

Notes Payable and Note Payable - Other (Details - Derivative Liabilities) - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Debt Disclosure [Abstract]
Derivative liabilities, Beginning	$ 281,845
Change in fair value	213,053
Total Fair Value Derivative Liabilities	494,898
Write off due to conversions	(398,753)
Total fair value of derivative	96,145
Gain on extinguishment	(96,145)	$ 0
Derivative liabilities, Ending	$ 0	$ 281,845

Note Payable - Schedule of assu

Note Payable - Schedule of assumptions (Details) - $ / shares	Jun. 30, 2022	Nov. 19, 2019
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Share Price	$ 0.010	$ 0.01300
Measurement Input, Expected Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivatives, Determination of Fair Value	0.00%	0.00%
Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivatives, Determination of Fair Value	269.75%	809.71%
Measurement Input, Risk Free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivatives, Determination of Fair Value	0.0007%	0.0154%
Measurement Input, Expected Term [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivatives, Determination of Fair Value	1.9288	0.75
Measurement Input, Exercise Price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivatives, Determination of Fair Value	$0.00550	$0.02

Notes Payable and Note Payabl_3

Notes Payable and Note Payable - Other (Details - Notes payable) - USD ($)	Jun. 30, 2022	Jun. 30, 2021
Debt Instrument [Line Items]
Notes Payable	$ 174,243	$ 238,244
Loans Payable	238,856	615,000
Notes Payable, Current	413,099	853,244
Wells Fargo Loan [Member]
Debt Instrument [Line Items]
Notes Payable	8,770	12,454
On Deck Loan [Member]
Debt Instrument [Line Items]
Notes Payable	139,569	139,569
Susquehanna Salt Loan [Member]
Debt Instrument [Line Items]
Notes Payable	10,500	52,500
Prosper Loans [Member]
Debt Instrument [Line Items]
Notes Payable	9,994	17,771
M A R C U S Loan [Member]
Debt Instrument [Line Items]
Notes Payable	$ 5,410	$ 15,950

Notes Payable and Notes Payab_3

Notes Payable and Notes Payable - Other (Details Narrative) - USD ($)						1 Months Ended				4 Months Ended	12 Months Ended
	Oct. 26, 2021	Oct. 06, 2021	Aug. 27, 2021	Jul. 29, 2021	Nov. 19, 2019	Nov. 30, 2021	Jul. 31, 2020	Jan. 31, 2015	Sep. 30, 2014	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2020	Dec. 31, 2019	Aug. 19, 2021	Jun. 04, 2021	Sep. 30, 2020	Nov. 30, 2016	Jun. 30, 2016	Mar. 03, 2016	Mar. 01, 2016	Jun. 30, 2015
Debt Instrument [Line Items]
Short term notes payable										$ 500,000	$ 100,000	$ 500,000
Interest and accrued interest liability											21,649	55,027
Principle amount repaid															$ 300,000
Repayment of debt						$ 100,000
Interest Payable, Current											76,677
Notes payable										238,244	174,243	238,244
Interest Payable										28,225	49,415	28,225
Derivative liabilities										281,845	0	281,845
Gain (Loss) on Extinguishment of Debt											$ 96,145	0
Borrowed amount									$ 500,000
Rate of interest											16.24%
Maturity date									Sep. 30, 2017
Increased amount								$ 500,000
Accrued Interest																			$ 25,653			$ 8,436
Line of credit balance										397,500	$ 397,500	397,500
Notes payable, current										853,244	413,099	853,244
Gain on debt forgiveness											$ 81,000
MCA Cure [Member]
Debt Instrument [Line Items]
Loan payments													$ 47,000	$ 43,875
Reserve fund																	$ 90,875
Minimum [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate During Period											9.24%
Maximum [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate During Period											10.90%
Medi Pendant New York Inc [Member]
Debt Instrument [Line Items]
Rate of interest									6.50%
Issuance of shares								200,000
B2CF [Member]
Debt Instrument [Line Items]
Convertible notes																					$ 13,750
BENZA [Member]
Debt Instrument [Line Items]
Convertible notes																				$ 660,000
BENZA and D2CF [Member]
Debt Instrument [Line Items]
Convertible notes										673,750	$ 673,750	673,750
Leonite Convertible Note [Member]
Debt Instrument [Line Items]
Company recieved amount					$ 135,000
Convertible note face value					150,000											$ 260,000
Original Issue Discount					$ 15,000
Stock issued for debt shares					2,700,000
Derivative liabilities					$ 94,225
MCA Cure [Member]
Debt Instrument [Line Items]
Notes payable											0
On Deck Loan [Member]
Debt Instrument [Line Items]
Notes payable										139,569	139,569	139,569
Susquehanna Salt Loan [Member]
Debt Instrument [Line Items]
Notes payable										52,500	10,500	52,500
Party Related to Former CEO [Member]
Debt Instrument [Line Items]
Interest Payable										9,283	11,283	9,283
Other Notes Payable																		$ 50,000
Debt Instrument, Interest Rate, Stated Percentage																		4%
Interest Expense, Debt											2,000	2,000
Leonite [Member]
Debt Instrument [Line Items]
Convertible notes										260,000	0	260,000
Debt Instrument, Convertible, Liquidation Preference, Value	$ 125,000	$ 57,952	$ 44,475	$ 42,750
Debt Instrument, Fee Amount	$ 2,250	$ 2,250	$ 2,250	$ 2,250
Debt Conversion, Converted Instrument, Shares Issued	27,917,969	13,231,209	10,269,253	15,000,000
Gain (Loss) on Extinguishment of Debt											96,145
Regulation A Filing [Member] | Two Unaffiliated Investors [Member]
Debt Instrument [Line Items]
Proceeds from Issuance or Sale of Equity										115,000
Notes payable										115,000	115,000	115,000
Interest Payable										$ 1,539	$ 1,539	$ 1,539
COHEN [Member]
Debt Instrument [Line Items]
Short term bridge loan							$ 500,000
Interest rate							12%
Accrue interest							12%

Shareholders_ (Deficit) (Detail

Shareholders’ (Deficit) (Details Narrative) - USD ($)		1 Months Ended		12 Months Ended
	Sep. 02, 2020	Dec. 31, 2020	Nov. 30, 2019	Jun. 30, 2022	Jun. 30, 2021	Nov. 19, 2019
Class of Stock [Line Items]
Preferred stock, shares authorized				25,000,000	25,000,000
Preferred stock, par value				$ 0.0001	$ 0.0001
Shares issued for purchase of asset	6,700,003
Number of shares sold			4,000,000
Number of sahres canceled					4,000,000
Number of shares issued, value				$ 3,399,999
Shares price				$ 0.010		$ 0.01300
Stock issued for services, value				$ 295,000	$ 48,300
Common stock, shares authorized				3,000,000,000	3,000,000,000
Common stock, par value				$ 0.0001	$ 0.0001
Stock Issued During Period, Value, New Issues				$ 215,000	$ 1,554,000
Common stock, shares issued				1,493,142,608	647,074,177
Common stock, shares outstanding				1,493,142,608	647,074,177
Reg A Offering [Member]
Class of Stock [Line Items]
Number of shares sold				360,000,000	145,400,000
[custom:StockAccruedDuringPeriodSharesNewIssues]					10,000,000
[custom:StockAccruedDuringPeriodValueNewIssues]					$ 100,000
Public Sales [Member]
Class of Stock [Line Items]
Number of shares sold				409,650,000
Stock Issued During Period, Value, New Issues				$ 6,556,845
Officer Bonuses [Member]
Class of Stock [Line Items]
[custom:StockAccruedDuringPeriodSharesShareBasedCompensationGross]					150,000
[custom:StockAccruedDuringPeriodSharesValueBasedCompensationGross]					$ 1,500
Stock Issued For Services [Member]
Class of Stock [Line Items]
Stock issued for services, shares				10,000,000	3,000,000
Stock issued for services, value				$ 48,300	$ 48,300
Shares Issued For Debt Conversion [Member]
Class of Stock [Line Items]
Debt Conversion, Converted Instrument, Shares Issued				66,418,431
Debt Conversion, Converted Instrument, Amount				$ 260,000
[custom:DebtConversionConvertedInterestAmount1]				9,954
[custom:DebtConversionConvertedFeeAmount1]				9,000
Stock Issued During Period, Value, Conversion of Convertible Securities				$ 677,707
Officers Compensation And Bonuses [Member]
Class of Stock [Line Items]
[custom:StockAccruedDuringPeriodSharesShareBasedCompensation]				7,262,500
[custom:StockAccruedDuringPeriodValueShareBasedCompensation]				$ 104,126
Employee Compensation And Bonuses [Member]
Class of Stock [Line Items]
[custom:StockAccruedDuringPeriodSharesShareBasedCompensation]				6,840,000
[custom:StockAccruedDuringPeriodValueShareBasedCompensation]				$ 88,551
Directors [Member]
Class of Stock [Line Items]
Stock issued for services, shares					200,000,000
Stock issued for services, value					$ 1,140,000
Officers [Member]
Class of Stock [Line Items]
Number of shares issued for compensation					1,275,000
Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture					$ 8,518
Series E Convertible Stock [Member]
Class of Stock [Line Items]
Number of shares issued		900,000
Number of shares issued, value		$ 513,000
Shares price		$ 0.57
Stock issued for services, shares		100,000
Stock issued for services, value		$ 57,000
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized				100,000	100,000
Preferred stock, par value				$ 0.0001	$ 0.0001
Preferred stock, shares issued				688	688
Preferred stock, shares outstanding				688	688
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized				62,500	62,500
Preferred stock, par value				$ 0.0001	$ 0.0001
Preferred stock, shares issued				9,938	9,938
Preferred stock, shares outstanding				9,938	9,938
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized				6,944,445	6,944,445
Preferred stock, par value				$ 0.0001	$ 0.0001
Preferred stock, shares issued				6,838,889	6,838,889
Preferred stock, shares outstanding				6,838,889	6,838,889
Series C Preferred Stock [Member] | Director [Member]
Class of Stock [Line Items]
Shares issued				1,000,000
Series D Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized				500,000	500,000
Preferred stock, par value				$ 0.0001	$ 0.0001
Preferred stock, shares issued				425,000	425,000
Preferred stock, shares outstanding				425,000	425,000
Series E Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized				4,000,000	4,000,000
Preferred stock, par value				$ 0.0001	$ 0.0001
Preferred stock, shares issued				4,000,000	1,900,000
Preferred stock, shares outstanding				4,000,000	1,900,000
Common stock voting right				Each of these shares carries a voting right equivalent to 10,000 shares of common stock.
Shares issued		1,000,000
Series E Preferred Stock [Member] | Director 1 [Member]
Class of Stock [Line Items]
Stock issued for services, shares				1,000,000
Series E Preferred Stock [Member] | Director 2 [Member]
Class of Stock [Line Items]
Stock issued for services, shares				1,000,000
Series E Preferred Stock [Member] | Two Directors [Member]
Class of Stock [Line Items]
Stock issued for services, value				$ 3,000,000
Series E Preferred Stock [Member] | Director [Member]
Class of Stock [Line Items]
Issued amount				$ 650,000
Issued price				$ 0.65
Series E Preferred Stock [Member] | Two Director [Member]
Class of Stock [Line Items]
Shares issued		450,000
Common Stock [Member]
Class of Stock [Line Items]
Number of shares sold			200,000,000

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Jun. 30, 2022	Jun. 30, 2021
Related Party Transactions [Abstract]
Related parties – subsidiary	$ 202,875	$ 263,473
Due from related parties	(155,800)	0
Accrued salaries, bonus, fees	10,965	316,200
Total loans from related parties, net	$ 58,040	$ 579,673

Related Party Transactions (D_2

Related Party Transactions (Details Narrative) - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Related Party Transaction [Line Items]
Accrued interest	$ 49,415	$ 28,225
Debt expensed	21,190	28,225
Boapin [Member]
Related Party Transaction [Line Items]
Note payable	$ 170,000	$ 425,000

Commitments and contingencies_2

Commitments and contingencies (Details) - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Rent expense	$ 15,700	$ 15,325

Other income - settlement (Deta

Other income - settlement (Details Narrative) - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2019	Feb. 28, 2022
Other Income and Expenses [Abstract]
Payment for contract services			$ 97,625
Attorney costs				$ 105,125
Settlement income	$ 36,000	$ 0

Income Taxes (Details - Schedul

Income Taxes (Details - Schedule of Effective tax rate)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Income Tax Disclosure [Abstract]
U.S. statutory rate	21%	21%
PA state corporate tax	9.99%	9.99%
Less valuation allowance	(30.99%)	(30.99%)
Effective tax rate	0%	0%

Income Taxes (Details - Sched_2

Income Taxes (Details - Schedule of deferred tax asset) - USD ($)	Jun. 30, 2022	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Net deferred tax assets	$ 12,217,306	$ 8,337,244
Less valuation allowance	(12,217,306)	(8,337,244)
Deferred tax asset - net valuation allowance	$ 0	$ 0

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	Jun. 30, 2022	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Operating Loss Carryforwards	$ 39,423,382	$ 26,903,013